Stay updated on Fremanezumab, Migraine, Sleep Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab, Migraine, Sleep Clinical Trial page.

Latest updates to the Fremanezumab, Migraine, Sleep Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s displayed ClinicalTrials.gov interface revision updates from v3.5.2 to v3.5.3 without indicating any study record content changes.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.5.2 was added to the history; Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe record history now shows revision v3.5.0 added and v3.4.3 removed; no substantive content changes to the study details are reflected.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded entries noting poor enrollment and that results have been posted, with updates to Outcome Measures (Results), Outcome Measures, and Study Status. A prior narrative about enrollment difficulties and termination was deleted.SummaryDifference0.8%

- Check66 days agoChange DetectedReturned: 2026-02-24 with updates to core study content including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Arms/Interventions, and Study Status, and a note that Quality Control Review Has Not Concluded.SummaryDifference1%

Stay in the know with updates to Fremanezumab, Migraine, Sleep Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab, Migraine, Sleep Clinical Trial page.